Prothena Corporation PLC
NASDAQ:PRTA
Prothena Corporation PLC
NASDAQ:PRTA
Price:
22.93 USD
4.04%
Market Closed
Updated:
May 4, 2024
Prothena Corporation PLC
Cash from Financing Activities
|
Prothena Corporation PLC
Cash from Financing Activities Peer Comparison
Comparables:
ALKS
AMRN
M
MURA
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Cash from Financing Activities
$45.1m
|
CAGR 3-Years
490%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-6%
|
|
|
Alkermes Plc
NASDAQ:ALKS
|
Cash from Financing Activities
-$289.7m
|
CAGR 3-Years
-409%
|
CAGR 5-Years
-183%
|
CAGR 10-Years
N/A
|
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Cash from Financing Activities
$230k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-74%
|
CAGR 10-Years
-47%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Cash from Financing Activities
$468.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Prothena Corporation PLC's Cash from Financing Activities?
Cash from Financing Activities
45.1m
USD
45.1m
USD
Based on the financial report for Dec 31, 2023, Prothena Corporation PLC's Cash from Financing Activities amounts to 45.1m USD.
What is Prothena Corporation PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-6%
-6%
Over the last year, the Cash from Financing Activities growth was -81%. The average annual Cash from Financing Activities growth rates for Prothena Corporation PLC have been 490% over the past three years , 2% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
